NCPL vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 04, 2026
NCPL
HIVE
Investment Advisor Scores
HIVE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NCPL | HIVE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 62.8931 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -38.2% | 73.5% | HIVE |
| Earnings Growth | -10.0% | -99.9% | NCPL |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 29.4/100 | 40.3/100 | HIVE |
| Profit Margin | 0.0% | -98.5% | NCPL |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NCPL
MarkupPrice above SMA50, rising 50-day trend (32.5% over 20 days), RSI 66
HIVE
DistributionPrice near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | NCPL | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | -5.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.4% | 0.7% |
| Gross Margin | 1.0% | 0.4% |
| Operating Margin | -23.6% | -0.6% |
| EPS | -15.17 | -1.39 |
| Dividend Yield | — | — |